THR作为一种新型 Carotid 狭窄症生物标志物 严重性急性缺血性中风:对风险分层和个性化管理的影响
Cong Wu1, Yi Lv2, Conghuan Wang3
1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
概括
总胆固醇与高密度脂蛋白胆固醇 (THR) 的比率有效地预测了急性缺血性中风 (AIS) 患者的心血管狭窄的严重程度. 这种具有成本效益的生物标志物有助于风险分层和个性化治疗策略.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 生物标志物 生物标志物
背景情况:
- 急性缺血性中风 (AIS) 患者经常有同时发生的动脉狭窄症.
- 评估动脉狭窄症的严重程度对于中风风险分层和管理至关重要.
- 需要新的生物标志物来预测AIS中的狭窄严重程度.
研究的目的:
- 研究总胆固醇与高密度脂蛋白胆固醇比率 (THR) 在AIS患者心血管狭窄严重性的预测作用.
- 评估THR在风险评估和治疗决策中的临床实用性,用于患有动脉狭窄症的AIS患者.
主要方法:
- 180名患有心血管狭窄症的AIS患者按严重程度 (轻度,中度,严重) 分组,与180名健康对照人进行比较.
- 冠状动脉狭窄的诊断和分级使用数字减去血管学.
- 总胆固醇与高密度脂蛋白胆固醇比率 (THR) 和脂质资料在入院后24小时内被分析;统计分析包括ANOVA,ROC曲线和多变量回归.
主要成果:
- 与对照组相比,AIS患者的THR水平显著更高 (3.80 ± 1.07对3.02 ± 0.67,p < 0.05).
- THR显示与大脑动脉狭窄的严重程度有正相关性 (p < 0.05).
- ROC分析显示了强大的诊断准确性 (AUC:0.807),THR截止值为4.15,表明严重狭窄症的敏感度为81.1%,特异性为95.6%.
结论:
- 总胆固醇与高密度脂蛋白胆固醇的比率 (THR) 是一个有价值的,独立的生物标志物,用于评估AIS中的大脑动脉狭窄的严重程度.
- THR是一种具有成本效益的工具,可以提高风险分层,并指导AIS患者的个性化护理.
- 临床应用THR可以改善患者管理和急性缺血性中风的结果.
相关概念视频
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
395
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
395
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
470
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
470
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:23Atherosclerosis IV: Nursing Management
366
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
366
01:30Acute Coronary Syndrome III: Diagnostic Studies
215
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
800
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800